Vitamin D deficiency in Crohn's disease: Prevalence, risk factors and supplement use in an outpatient setting

Journal of Crohn's and Colitis

Volumn 6, Issue 2, 2012, Pages 182-188

  Nic Suibhne, Treasa ^a   Cox, Gerry ^b   Healy, Martin ^b   O'Morain, Colm ^a   O'Sullivan, Maria ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

25 hydroxyvitamin D; Diet; Inflammatory bowel disease; Nutrition; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; FAMILY HISTORY; FEMALE; HUMAN; MALE; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SUMMER; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WINTER;

ADULT; AMBULATORY CARE; CROHN DISEASE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEASONS; SMOKING; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84856744222     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.08.002     Document Type: Article

References (39)

1. British-Society-of-Gastroenterology Guidelines for osteoporosis in inflammatory bowel disease and coeliac disease 2007, last accessed Oct 2010. http://www.bsg.org.uk/clinical-guidelines/ibd/guidelines-for-osteoporosis-in-inflammatory-bowel-disease-and-coeliac-disease.html.
2. Bernstein C.N., Leslie W.D., Leboff M.S. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 2003, 124:791-794.
3. Dignass A., Van Assche G., Lindsay J.O., Lémann M., Söderholm J., Colombel J.F., Danese S., D'Hoore A., Gassull M., Gomollón F., Hommes D.W., Michetti P., O'Morain C., Oresland T., Windsor A., Stange E.F., Travis S.P. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010, 4:28-62. European Crohn's and Colitis Organisation (ECCO).
4. Bendix-Struve M., Bartels L.E., Agnholt J., Dige A., Jorgensen S.P., Dahlerup J.F. Vitamin D3 treatment of Crohn's disease patients increases stimulated T cell IL-6 production and proliferation. Aliment Pharmacol Ther 2010, 32:1364-1372.
5. Kelly P., Nic Suibhne T., O'Morain C., O'Sullivan M. Vitamin D Status and Cytokine Levels in Patients with Crohn's Disease. Int J Vitam Nutr Res 2011, 81. in press.
6. Miheller P., Muzes G., Hritz I., Lakatos G., Pregun I., Lakatos P.L., Herszenyi L., Tulassay Z. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis 2009, 15:1656-1662.
7. Jorgensen S.P., Agnholt J., Glerup H., Lyhne S., Villadsen G.E., Hvas C.L., Bartels L.E., Kelsen J., Christensen L.A., Dahlerup J.F. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010, 32:377-383.
8. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., Newmark H.L., Giovannucci E., Wei M., Holick M.F. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007, 32:210-216.
9. Cantorna M.T., Munsick C., Bemiss C., Mahon B.D. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000, 130:2648-2652.
10. Zhu Y., Mahon B., Froicu M., Cantorna M. Calcium and 1,25-dihydroxyvitamin D3 target the TNF-a pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005, 35:217-224.
11. Laverny G., Penna G., Vetrano S., Correale C., Nebuloni M., Danese S., Adorini L. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol Lett 2010, 131:49-58.
12. Tajika M., Matsuura A., Nakamura T., Suzuki T., Sawaki A., Kato T., Hara K., Ookubo K., Yamao K., Kato M., Muto Y. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol 2004, 39:527-533.
13. McCarthy D., Duggan P., O'Brien M., Kiely M., McCarthy J., Shanahan F., Cashman K.D. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther 2005, 21:1073-1083.
14. Gilman J., Shanahan F., Cashman K. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2006, 23:1007-1016.
15. Leslie W.D., Miller N., Rogala L., Bernstein C.N. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol 2008, 103:1451-1459.
16. Sentongo T., Semaeo E., Stettler N., Piccoli D., Stallings V., Zemel B. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 2002, 76:1077-1081.
17. Bours P.H., Wielders J.P., Vermeijden J.R., van de Wiel A. Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease. Osteoporos Int 2010 Nov 27, [Epub ahead of print] doi:10.1007/s00198-010-1484-y.
18. Siffledeen J., Siminoski K., Steinhart H., Greenberg G., Fedorak R. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol 2003, 17:473-478.
19. Pappa H.M., Gordon C.M., Saslowsky T.M., Zholudev A., Horr B., Shih M.C., Grand R.J. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006, 118:1950-1961.
20. Bakshi A., Nguyen H., Borum M. Vitamin D screening by gastroenterologists in patients with inflammatory bowel disease. Am J Gastroenterol 2009, 104:791.
21. Hypponen E., Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007, 85:860-868.
22. Gozdzik A., Barta J.L., Wu H., Wagner D., Cole D.E., Vieth R., Whiting S., Parra E.J. Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation. BMC Public Health 2008, 8:336.
23. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010, 121:297-300.
24. Gilman J., Shanahan F., Cashman K.D. Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr 2006, 60:889-896.
25. Farraye F.A., Nimitphong H., Stucchi A., Dendrinos K., Boulanger A.B., Vijjeswarapu A., Tanennbaum A., Biancuzzo R., Chen T.C., Holick M.F. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis 2011 Jan 6, [Epub ahead of print] doi:10.1002/ibd.21595.
26. Central-Statistics-Office Government of Ireland CSO Census-Principal Socio-Economic Results 2003.
27. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
28. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate?. J Steroid Biochem Mol Biol 2004, 89-90:611-614.
29. Heaney R. The Vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 2005, 97:13-19.
30. Webb A., Kline L., Holick M. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not provide vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988, 67:373-378.
31. Blalock S.J., Norton L.L., Patel R.A., Cabral K., Thomas C.L. Development and assessment of a short instrument for assessing dietary intakes of calcium and vitamin D. J Am Pharm Assoc 2003, 43:685-693.
32. Sanchez-Cano D., Ruiz-Villaverde R., Callejas-Rubio J.L., Perez C.C., Garcia M.G., Centeno N.O. Vitamin D deficiency and bone mineral density in Crohn's disease. Med Clin (Barc) 2011 Jun 11, 137(2):62-65.
33. Ulitsky A., Ananthakrishnan A.N., Naik A., Skaros S., Zadvornova Y., Binion D.G., Issa M. Vitamin d deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 2011, 35:308-316.
34. Birrenbach T., Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis 2004, 10:848-859.
35. Cashman K.D., Hill T.R., Lucey A.J., Taylor N., Seamans K.M., Muldowney S., Fitzgerald A.P., Flynn A., Barnes M.S., Horigan G., Bonham M.P., Duffy E.M., Strain J.J., Wallace J.M., Kiely M. Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 2008, 88:1535-1542.
36. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
37. Heaney R. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 80:1706S-1709S.
38. Kuwabara A., Tanaka K., Tsugawa N., Nakase H., Tsuji H., Shide K., Kamao M., Chiba T., Inagaki N., Okano T., Kido S. High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease. Osteoporos Int 2009, 20:935-942.
39. Jahnsen J., Falch J.A., Mowinckel P., Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002, 37:192-199.